Skip to main content
Clinical Trials/CTRI/2018/04/013527
CTRI/2018/04/013527
Active, not recruiting
Phase 2

A Clinical Study to Evaluate the Effect of Ayurvedic Formulationsin the management of Kamla (Jaundice) w.s.r. to Impaired Liver Function

Principal0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: null- patients with impaired LFT
Sponsor
Principal
Status
Active, not recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Principal

Eligibility Criteria

Inclusion Criteria

  • 1\. Patient willing to undergo trial and ready to give written consent.
  • 2\. Between the age group of 10 years and 70 years.
  • 3\. Patients presenting with signs and symptoms of Kamla and those having impaired liver function test.
  • 4\. Clinical evidence of infective hepatitis,cirrhosis of liver,parenchymal disease of liver,alcoholic liver disease etc.

Exclusion Criteria

  • 1\.Patients not willing for trial.
  • 2\.Patients who have developed malignancy and acute hepatocellular failure.
  • 3\.Patient in whom there is need of surgery, in case of obstructive jaundice.
  • 4\.Patients who have inherited hemoglobinopathy such as sickle cell anemia or thalassemia

Outcomes

Primary Outcomes

Not specified

Similar Trials